PRDM16::SKI is a predictor of aberrant expression of the short variant of PRDM16 in pediatric acute myeloid leukemia
Preprint
- 17 March 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
The RNA-sequencing data from the Japanese Children’s Cancer Group (JCCG)’s AML-05 study was re-analyzed to clarify the mechanisms related to high PRDM16 expressions, which is independently associated with adverse outcomes. Results showed that 19 of 139 patients presented with out-of-frame PRDM16::SKI fusions. Thus, the gene expression levels of PRDM16::SKI in 369 and 329 patients from the AML-05 and AML-12 studies, respectively, were measured. In total, 119 (32%) of 369 patients in the AML-05 study and 58 (18%) of 329 patients in the AML-12 study presented with an aberrant expression of PRDM16::SKI. This fusion was a 48-base-pair product that immediately formed a stop codon on the SKI side. The introduction of this product in mice did not cause AML. Intriguingly, none of the patients presented with SKI::PRDM16, which is reciprocal. Moreover, partner fusion genes were not detected in front of truncated PRDM16, indicating that a short form of PRDM16, which lacked exon 1, existed by itself. Patients with high PRDM16::SKI expression had significantly worse overall survival and event-free survival than those with a low PRDM16 expression. The cleavage between exons 1 and 2 of PRDM16 induces aberrant PRDM16 expression, and a strong associations was observed between PRDM16::SKI and PRDM16 expression.Keywords
All Related Versions
This publication has 39 references indexed in Scilit:
- UBTF‐internal tandem duplication as a novel poor prognostic factor in pediatric acute myeloid leukemiaGenes, Chromosomes and Cancer, 2022
- Clinical features and prognostic impact of PRDM16 expression in adult acute myeloid leukemiaGenes, Chromosomes and Cancer, 2017
- A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease MutationCell, 2015
- High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AMLLeukemia, 2015
- Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in childrenLeukemia, 2013
- NUP98‐NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemiaGenes, Chromosomes and Cancer, 2013
- NUP98/JARID1A is a novel recurrent abnormality in pediatric acute megakaryoblastic leukemia with a distinct HOX gene expression patternLeukemia, 2013
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AMLLeukemia, 2008
- Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: A study of the Japanese childhood AML Cooperative Study GroupPediatric Blood & Cancer, 2007